Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OCREVUS
- B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis
- Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis
- Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
- Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
- Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
- Effects of Ocrevus in Relapsing Multiple Sclerosis
- Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
- Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine
- A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
- Short-term B-cell Depletion in Relapsing Multiple Sclerosis
- Safety of Switching From Rituximab to Ocrelizumab in MS Patients
- Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
Clinical trials list
click for details